Edition:
United States

Alere Inc (ALR)

ALR on New York Consolidated

50.46USD
20 Sep 2017
Change (% chg)

$-0.05 (-0.09%)
Prev Close
$50.50
Open
$50.47
Day's High
$50.64
Day's Low
$50.41
Volume
635,889
Avg. Vol
1,553,644
52-wk High
$50.64
52-wk Low
$34.41

Chart for

About

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals... (more)

Overall

Beta: 0.21
Market Cap(Mil.): $4,422.66
Shares Outstanding(Mil.): 87.58
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.13 16.25
EPS (TTM): -- -- --
ROI: -- 9.49 14.87
ROE: -- 14.72 13.89

BRIEF-Alere announces intent to voluntarily delist Series B Convertible Perpetual Preferred Stock from the NYSE

* Alere announces intent to voluntarily delist Series B Convertible Perpetual Preferred Stock from the NYSE conditioned upon the completion of its acquisition by Abbott

Sep 18 2017

BRIEF-Quidel announces revised agreement for pending acquisition of Alere’s business

* Quidel announces revised agreement for its pending acquisition of Alere’s B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter Analyzers

Sep 18 2017

BRIEF-Abbott extends cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere

* Abbott announces extension of cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere

Sep 01 2017

Alere to face narrowed securities fraud lawsuit

A federal judge has significantly narrowed a shareholder lawsuit accusing Alere Inc and its senior executives of making false and misleading statements in the lead up to the announcement of a deal to sell the diagnostic testing company to Abbott Laboratories Inc.

Aug 24 2017

BRIEF-Abbott announces extension of cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere Inc

* Abbott announces extension of cash tender offer for all outstanding shares of series B convertible perpetual preferred stock of Alere Inc

Aug 14 2017

BRIEF-Alere Inc enters into purchase agreement with Siemens Diagnostics ​‍​

* Says ‍on July 21, 2017, Alere entered into purchase agreement with Siemens Diagnostics Holding II B.V. ​‍​

Jul 21 2017

UPDATE 3-Abbott profit forecast gets a lift from St. Jude integration

* Shares rise as much as 2.8 pct to $50.83 (Adds conference call details; updates shares)

Jul 20 2017

BRIEF-Alere launches Alere iCup Rx Drug Screen

* Alere launches Alere iCup Rx Drug Screen for detecting commonly misused and abused prescription drugs Source text for Eikon: Further company coverage:

Jul 19 2017

BRIEF-Abbott says commences tender offer for Series B preferred stock of Alere

* Abbott commences cash tender offer for all outstanding shares of series b convertible perpetual preferred stock of Alere Inc

Jul 17 2017

BRIEF-Quidel announces definitive agreement to acquire Alere Triage assets

* Quidel Corp - ‍accretive transactions extend Quidel's market leadership and position it for future growth​

Jul 17 2017

Competitors

Earnings vs. Estimates